With the recent surge in listings of psychedelic and mushrooms companies on Canadian stock exchanges in the past few months, there is a lot of hype surrounding the once touted illegal element. This week, we discuss the parallels between the current cannabis industry and what will need to unfold before there is any type of legitimacy of psychedelics playing in the major economic activities in North America. We also highlight what to look for in companies when allocating a small percentage of your capital in your portfolio.
